Trials / Completed
CompletedNCT00401362
A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients
A Double-Blind Placebo-Controlled Study of Methylnaltrexone (MNTX) for the Relief of Constipation Due to Chronic Opioid Therapy in Patients With Advanced Medical Illness
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 154 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To test the effectiveness of MNTX in advanced illness subjects.
Detailed description
To determine the efficacy of MNTX compared to placebo to induce laxation in patients receiving opioids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SC Methylnaltrexone | Dose 1 |
| DRUG | SC Placebo | |
| DRUG | SC Methylnaltrexone | Dose 2 |
Timeline
- Start date
- 2003-02-01
- Primary completion
- 2005-02-01
- Completion
- 2005-02-01
- First posted
- 2006-11-20
- Last updated
- 2019-11-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00401362. Inclusion in this directory is not an endorsement.